{"id":31370,"date":"2025-04-08T15:08:30","date_gmt":"2025-04-08T07:08:30","guid":{"rendered":"https:\/\/flcube.com\/?p=31370"},"modified":"2025-04-08T15:08:32","modified_gmt":"2025-04-08T07:08:32","slug":"beijing-unveils-measures-to-accelerate-innovative-drug-development-and-regulatory-efficiency","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31370","title":{"rendered":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency"},"content":{"rendered":"\n

The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city’s innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.<\/p>\n\n\n\n

Clinical Trial Efficiency<\/strong>
The measures aim to benchmark international standards by reducing the initiation timeline for clinical trials to within 20 weeks and increasing the mutual recognition rate of ethical reviews for multi-center trials to over 90%. Initiatives include the development of automated and intelligent biological sample libraries for key diseases and the expansion of international clinical trial capabilities.<\/p>\n\n\n\n

Regulatory Review Acceleration<\/strong>
Beijing is streamlining its review and approval processes, cutting the approval time for innovative drug clinical trials from 60 to 30 working days. The city also plans to expand the variety of innovative drug pilot projects and reduce the review time for drug supplement applications from 200 to 60 working days. By 2025, the goal is to approve at least 15 new innovative pharmaceutical and medical products annually.<\/p>\n\n\n\n

Production and Market Support<\/strong>
The measures support cross-border production for overseas drug marketing authorization holders and expand import categories for rare disease drugs. Beijing will also facilitate the import of urgently needed clinical drugs and medical devices through expedited approval channels.<\/p>\n\n\n\n

Clinical Use Innovation<\/strong>
National negotiation drugs will be directly included in the drug catalogs of designated medical institutions, with innovative drugs granted expedited listing and excluded from medical insurance self-payment rate indicators.<\/p>\n\n\n\n

AI in Drug Development<\/strong>
Beijing will establish collaborative mechanisms for medical data annotation and encourage the creation of AI research and development centers to enhance drug innovation.<\/p>\n\n\n\n

Investment and Financing Support<\/strong>
The city will establish a pharmaceutical and health industry fund of RMB 50 billion (USD 683 million) and a pharmaceutical M&A fund of RMB 10 billion (USD 137 million), leveraging existing investment funds to strengthen listing and financing services.<\/p>\n\n\n\n

Industry Layout Optimization<\/strong>
Plans include constructing an international pharmaceutical innovation park and enhancing the industrial capacity of Zhongguancun Life Science Park.<\/p>\n\n\n\n

Talent and Intellectual Property<\/strong>
Beijing will cultivate and introduce 1,000 outstanding talents and improve intellectual property services to support innovation in the pharmaceutical sector.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the…<\/p>\n","protected":false},"author":1,"featured_media":31371,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[67],"class_list":["post-31370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-nhsa-prev-smia"],"yoast_head":"\nBeijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31370\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency\" \/>\n<meta property=\"og:description\" content=\"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31370\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-08T07:08:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-08T07:08:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency\",\"datePublished\":\"2025-04-08T07:08:30+00:00\",\"dateModified\":\"2025-04-08T07:08:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370\"},\"wordCount\":379,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0807-png.webp\",\"keywords\":[\"NHSA (prev. SMIA)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31370#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31370\",\"name\":\"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0807-png.webp\",\"datePublished\":\"2025-04-08T07:08:30+00:00\",\"dateModified\":\"2025-04-08T07:08:32+00:00\",\"description\":\"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31370\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0807-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0807-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31370#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency - Insight, China's Pharmaceutical Industry","description":"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31370","og_locale":"en_US","og_type":"article","og_title":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency","og_description":"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.","og_url":"https:\/\/flcube.com\/?p=31370","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-08T07:08:30+00:00","article_modified_time":"2025-04-08T07:08:32+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31370#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31370"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency","datePublished":"2025-04-08T07:08:30+00:00","dateModified":"2025-04-08T07:08:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31370"},"wordCount":379,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31370#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","keywords":["NHSA (prev. SMIA)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31370#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31370","url":"https:\/\/flcube.com\/?p=31370","name":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31370#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31370#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","datePublished":"2025-04-08T07:08:30+00:00","dateModified":"2025-04-08T07:08:32+00:00","description":"The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the \u201cSeveral Measures to Support the High-quality Development of Innovative Drugs in Beijing (2025),\u201d effective immediately. These 32 measures are designed to enhance the city's innovative drug ecosystem through improvements in clinical trial efficiency, regulatory review processes, production support, market access, and investment promotion.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31370#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31370"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31370#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","width":1080,"height":608,"caption":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31370#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0807-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31370"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31370\/revisions"}],"predecessor-version":[{"id":31372,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31370\/revisions\/31372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31371"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}